Fanconi anemia
ICD-10 D61.03 is a billable code used to indicate a diagnosis of fanconi anemia.
Fanconi anemia is a rare genetic disorder characterized by aplastic anemia, which results from the failure of bone marrow to produce sufficient blood cells. This condition is caused by mutations in genes responsible for DNA repair, leading to increased sensitivity to DNA-damaging agents. Patients with Fanconi anemia often present with symptoms of bone marrow failure, including fatigue, pallor, and increased susceptibility to infections due to low white blood cell counts. The disorder can also manifest with physical anomalies, such as short stature, skeletal abnormalities, and skin pigmentation changes. Diagnosis typically involves a combination of clinical evaluation, family history, and specialized tests, including chromosomal breakage studies. Management may include supportive care, blood transfusions, and hematopoietic stem cell transplantation, which is the only curative treatment. Due to the genetic nature of the disorder, genetic counseling is also recommended for affected families. The complexity of coding for Fanconi anemia arises from its association with various hematopoietic disorders and the need for precise documentation of clinical findings and treatment plans.
Comprehensive documentation of blood counts, bone marrow biopsy results, and genetic testing.
Diagnosis and management of patients with unexplained anemia and bone marrow failure.
Ensure accurate coding of associated conditions and treatments, including stem cell transplantation.
Detailed family history and genetic testing results.
Counseling families with a history of Fanconi anemia and discussing genetic testing options.
Document the implications of genetic findings for family members and potential screening.
Used to evaluate bone marrow function in suspected cases of Fanconi anemia.
Document indications for the procedure and findings.
Hematology specialists should ensure accurate coding based on findings.
Fanconi anemia is primarily caused by genetic mutations that affect the body's ability to repair DNA, leading to bone marrow failure and increased cancer risk.
